Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-06-28
2011-06-28
Andres, Janet L (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S291000
Reexamination Certificate
active
07968717
ABSTRACT:
The invention relates to a new crystalline anhydrate of tiotropium bromide, processes for preparing it and its use for preparing a pharmaceutical composition for the treatment of respiratory complaints, particularly for the treatment of COPD (chronic obstructive pulmonary disease) and asthma.
REFERENCES:
patent: 5610163 (1997-03-01), Banholzer et al.
patent: 6608055 (2003-08-01), Sieger et al.
patent: RE39820 (2007-09-01), Banholzer et al.
patent: 2004/0087793 (2004-05-01), Banholzer et al.
patent: 0418716 (1990-09-01), None
patent: WO 02/30928 (2002-04-01), None
Byrn, S.R. et. al. Chapter 3 “The X-Ray Powder Diffraction Method” in Solid State Chemistry of Drugs 2nd Edition, SSCI, 1999, pp. 59-67.
Littner, M. R. et. al. “Long-Acting Bronchodilation with Once-Daily Dosing of Tiotropium (Spiriva) in Stable Chronic Obstructive Pulmonary Disease” American Journal of Respiratory and Critical Care Medicine 2000, 161, 1136-1142.
“Guidelines for Authors” Journal of Organic Chemistry 2007, 72, 13A-27A.
Zell et. al. “Investigation of Polymorphism in Aspartame and Neotame Using Solid-State NMR Spectroscopy.” Tetrahedron 2000, 56, 6603-6616.
Stahl, P.H., et al. “Handbook of Pharmaceutical Salts Properties, Selection and Use”, 2002, Wiley-VCH, Weinheim-New York, p. 98, XP002268934.
B.Disse, et al. “Tiotopium (SpirivaTM): Mechanistical Considerations and Clinical Profile in Obstructive Lung Disease” Life Sciences, vol. 64, Nos. 6/7, p. 457-464, 1999.
Docoslis et al.; Characterization of the Distribution, Polymorphism, and Stability of Nimodipine in Its Solid Dispersions in Polyethylene Glycol by Micro-Raman Spectroscopy and Powder X-Ray Diffraction; The AAPS Journal 2007; vol. 9; No. 3; Article 43; pp. E361-E370.
Brittain; Physical Characterization of Pharmaceutical Solids; Drugs and the Pharmaceutical Sciences; vol. 70; pp. 2-35, 1995.
Pfrengle Waldemar
Sieger Peter
Andres Janet L
Boehringer Ingelhein International GmbH
Morris Michael P.
O'Dell D K
Petka Wendy A.
LandOfFree
Crystalline anhydrate with anticholinergic efficacy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline anhydrate with anticholinergic efficacy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline anhydrate with anticholinergic efficacy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2711150